Skip to main content
. 2020 Jan 16;19(3):2431–2445. doi: 10.3892/ol.2020.11311

Figure 3.

Figure 3.

Associations of long non-coding RNA expression levels with the clinical characteristics of patients with GC. (A) PTPRG-AS1 expression in the Ki67-positive group (n=41) and the Ki67-negative group (n=20). (B) ZXF2 expression was significantly higher in the Ki67-positive group. (C) ZXF2 expression was higher in patients with smaller tumor sizes (<6 cm). (D) FOXP4-AS1 expression was significantly higher in females than males. (E) BLACAT2; and (F) UCC expressions were significantly higher in males than females. (G) UCC expression was significantly elevated in the LNM-positive group than in the LNM-negative group. Error bars represent the mean ± SD. PTPRG-AS1, PTPRG antisense RNA 1; FOXP4-AS1, forkhead box P4 antisense RNA 1; BLACAT2, bladder cancer-associated transcript 2; UCC, upregulated in colorectal cancer; LNM, lymph node metastasis.